Search filters

Filters
Clear All

Phase

  • 182
  • 151
  • 2
  • 188
  • 147
  • 17
  • 373
  • 1196
  • 568
  • 28
  • 44
  • 2
  • 1128
  • 1197
  • 5

Found 1202 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma (CARTITUDE-2)
18 years - 99 years
All genders
Interventional
The purpose of this study is to see if JNJ-68284528 is safe and useful for treating patients with relapsed or refractory multiple myeloma.
18 years - 99 years
All genders
Phase 1
Interventional
The purpose of this study is to test the ability of a new drug, BGB324, to get into the brain tumor (e.g.by crossing the blood brain barrier) in patients with recurrent glioblastoma who require surgery.
18 years - 99 years
All genders
The research study is being conducted to determine the best mode of Cardiac Resynchronization Therapy (CRT) pacing for CRT patients. Participants will be asked to complete the following research procedure of a transthoracic echocardiogram (TTE) prior to their implant.
 Study of JNJ-75229414  a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against KLK2 for Metastatic Castration-Resistant Prostate Cancer
18 years - 99 years
Male
Phase 1
Interventional
The purpose of this study is to determine recommended Phase 2 dose (RP2D) regimen(s) of JNJ-75229414 in Part 1 (Dose Escalation and to determine safety at the RP2D regimen(s) in Part 2 (Dose Expansion).
18 years - 99 years
All genders
The EDIC Study is a follow-up study to the Diabetes Control and Complications Trail ( DCCT) conducted between 1983- 1993. The primary aim of the EDIC Study ( for years 2017-2022) is to examine the prevalence of cognitive, affective, and physical impairments in T1DM, and the association of DCCT treatment …
18 years - 99 years
All genders
Phase 3
The research study is being conducted to investigate the potential benefits of Enzastaurin in combination with temozolomide and radiation therapy in newly-diagnosed glioblastoma patients with the Denovo Genomic Marker1 (DGM1).
 A  Study of Osimertinib with or without Platinum Plus Pemetrexed Chemotherapy  as First-line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation- Positive  Locally Advanced or Metastatic Non-small Cell Lung Cancer
18 years - 99 years
All genders
Phase 3
Interventional
The purpose of this study is to try to find out if an experimental combination of an oral medication called osimertinib when used in combination with chemotherapy is more effective than giving osimertinib alone for the treatment of non-small cell lung cancer (NSCLC). Eligible subjects will be adult subjects with …
18 years - 99 years
All genders
This study will measure the amount of a protein in the brain known as tau using an imaging procedure called Positron Emission Tomography (PET/CT). Findings from this study lead to a better understanding of factors that influence the course of Alzheimer’s and other diseases of aging. Participation in this study …
18 years - 99 years
All genders
Interventional
We are developing an investigational test that is designed to guide individualized care in patients who have a heart attack.
 A Study of Itolizumab in Combination with Corticosteroids for the Initial Treatment of Acute Graft Versus Host Disease
18 years - 99 years
All genders
Phase 3
The main purpose of this study is to test the efficacy and safety (benefit and risks) of itolizumab, when added to corticosteroids, as treatment for aGVHD.
431 - 440 of 1202